堀本義哉

Horimoto Yoshiya

所属機関・部署：

研究分野 (1件)：腫瘍診断、治療学

競争的資金等の研究課題 (11件)：

全件表示

論文 (114件)：

Yoshiya Horimoto, Hiroko Onagi, Junichiro Watanabe, Takuo Hayashi. HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti-HER-2/neu (4B5). Pathology international. 2024. 74. 2. 99-101
Toshitaka Uomori, Yoshiya Horimoto, Yuko Ueki, Yumiko Ishizuka, Hiroko Onagi, Takuo Hayashi, Junichiro Watanabe, Naoto Shikama. Efficacy of radiation therapy in Japanese patients with positive margins after breast-conserving surgery. Japanese journal of clinical oncology. 2024
Yoshiya Horimoto, May Thinzar Hlaing, Harumi Saeki, Kaori Denda-Nagai, Katrin Ishii-Schrade, Haruhiko Fujihira, Masaaki Abe, Miki Noji, Shigeyuki Shichino, Mitsue Saito, et al. Glycosylation profiles of breast cancer cells may represent clonal variations of multiple organ metastases. Clinical & experimental metastasis. 2024
Harumi Saeki, Yoshiya Horimoto, May Thinzar Hlaing, Yuan Men, Lu Rong, Yumiko Ishizuka, Toshitaka Uomori, Emiko Yoshida, Yasuhisa Terao, Atsushi Arakawa, et al. Clinicopathological and molecular pathological characteristics in tamoxifen-related endometrial cancer. Oncology letters. 2024. 27. 1. 9-9
Moe Itakura, Yoshiya Horimoto, Yumiko Ishizuka, Hiroko Onagi, Takuo Hayashi, Toshio Kawamoto, Junichiro Watanabe, Kotaro Iijima. IgG4-related mastitis characterized by skin thickening of the breast: a case report. Surgical case reports. 2023. 9. 1. 192-192

MISC (46件)：

植木優子, 饗場恵美子, 播野裕子, 市川佑一, 新行内芳明, 堀本義哉, 中井克也, 飯島耕太郎, 水野博司, 齊藤光江. 当院におけるインプラント再建の現状. 日本乳癌学会総会プログラム抄録集. 2020. 28回. 88-88
Yoshiya Horimoto, Emi Tokuda, Fumi Murakami, Katsuya Nakai, Hideo Shimizu, Mitsue Saito. MESENCHYMAL CIRCULATING TUMOUR CELL ANALYSIS TO PREDICT EFFICACY OF ERIBULIN FOR METASTATIC BREAST CANCER PATIENTS. BREAST. 2017. 36. S40-S41
佐伯春美, 梶野一徳, 堀本義哉, Wali Nadila, Thinzar Hlaing May, 大辻奈穂美, 樋野興夫. 子宮内膜癌におけるミスマッチ修復異常と腫瘍内浸潤リンパ球. 日本癌学会総会記事. 2017. 76回. P-1119
Akiko Ogiya, Kieko Yamazaki, Rie Horii, Tadahiko Shien, Yoshiya Horimoto, Norikazu Masuda, Touko Inao, Mitsuchika Hosoda, Naoko Ishida, Tomofumi Osako, et al. Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer (vol 24, pg 473, 2017). BREAST CANCER. 2017. 24. 4. 642-642
M. Saito, K. Iijima, K. Nakai, Y. Horimoto, M. Mori, T. Himuro, T. Uomori, F. Murakami, A. Arakawa, K. Sasai. Risk factors for locoregional recurrence after post-mastectomy radiation therapy (PMRT) and chemotherapy in patients with 4 or more metastatic nodes. BREAST. 2017. 32. S74-S75

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

堀本 義哉